-
The State Food and Drug Administration Revises the Instructions for Mouse Nerve Growth Factor for Injection
Time of Update: 2021-03-26
Administration issued an announcement on the revision of the instructions for mouse nerve growth factor for injection, and decided to revise the instructions for mouse nerve growth factor for injection [adverse reactions], [precautions] and medications
-
The State Food and Drug Administration revises the instructions for systemic fluoroquinolones
Time of Update: 2021-03-26
Add the following content under [Notes] Risk of aortic aneurysm and aortic dissection Epidemiological studies report an increase in the incidence of aortic aneurysm and aortic dissection within two months after the use of fluoroquinolones, especially in elderly patients.
-
South Korea issues import inspection instructions for kimchi and pickled cabbage made in China
Time of Update: 2021-03-20
html" class="zdbq" title="Preserved food related food information" target="_blank">pickled food foodmate.
html" class="zdbq" title="Preserved food related food information" target="_blank">pickled food foodmate.
-
The State Drug Administration revised the instruction manual for quick-acting heart-saving pills, requiring warning signs to include "pregnant women banned"
Time of Update: 2021-03-10
In accordance with the revised requirements, quick-acting heart-saving pill instructions should include the prohibition of pregnant women, "adverse reactions" should increase nausea, vomiting, dry mouth, headache, dizziness, rash, itching, redness
-
NMPA: Revision of 巯 and methiciltic preparation instructions Adverse reactions, taboos and many other content
Time of Update: 2021-03-08
replace all factory-issued drug instructions and labels within 9 months of filing. II. Drug market license holders shall conduct in-depth research on the mechanism for the occurrence of new adverse reactions, take effective measures to do a good job
-
The State Drug Administration revised the six-flavored yellow preparation instruction manual
Time of Update: 2021-03-07
On February 18, the State Drug Administration issued a notice announcing that it had decided to revise the instructions (adverse reactions) and "precautions" for six-flavored yellow preparations (including pills, capsules, tablets, enseging agents
-
The State Drug Administration revised the instructions for gifeitinib tablets
Time of Update: 2021-03-05
After listing, adverse reaction monitoring has received reports of palm erythema syndrome (hand-foot syndrome, hand-foot skin reaction), which is manifested in abnormal palm and foot sensations, erythema, chippy, blisters, bleeding, cleft palate, edema or excessive ablation.
-
The State Drug Administration revised the six-flavored yellow preparation instruction manual
Time of Update: 2021-02-24
for six-flavored yellow preparations Requirements I, "adverse reactions" item should be added: Monitoring data show that six-flavored yellow preparations have diarrhea, abdominal pain, bloating, nausea, vomiting, gastrointestinal discomfort, loss
-
State Drug Administration: The six-flavored yellow preparation instructions for a unified revision
Time of Update: 2021-02-24
the safety of public drug use, the State Drug Administration decided to six-flavored yellow preparations (including pills, capsules, tablets, adhesives, omelettes, granules) instructions "adverse reactions" (taboos) and "precautions" to make
-
Six-flavored yellow pill modification instruction manual Adverse reactions increased by 13 items
Time of Update: 2021-02-24
Pharma Network February 20, recently, the State Drug Administration issued a notice on the revision of the six-flavored yellow preparation instructions, which added 13 adverse reactions. The State Drug Administration reminds the relevant drug
-
The six-flavored yellow instruction manual was changed to affect more than 500 pharmaceutical companies
Time of Update: 2021-02-24
, although the growth rate of sales in recent years is declining, but has been growing at an annual growth rate of about 50 million yuan in stable growth. the competitive landscape of enterprises, its market concentration is relatively high
-
State clear instructions: these 6 red lines, village doctors can not touch
Time of Update: 2021-02-13
the suspension of practicing activities for more than six months and not more than one year, and shall be fined from 10,000 yuan to 30,000 yuan; for village doctors, the above questions have a clear answer, we must not touch these red lines in their daily work.
-
Announcement of the General Administration on the revision of the instructions for the preparation of renal decay
Time of Update: 2021-02-08
" and "precautions" of the instructions for renal decay preparations. The relevant matters are heeded as follows: First, all manufacturers of renal decay preparations shall, in accordance with the relevant provisions of the Measures
-
The State Administration of Food and Drug Administration revised the instruction manual for indisin yellow injection: prohibited in newborns
Time of Update: 2021-02-08
On August 31st, the State Drug Administration issued a revised instruction manual for indisin yellow injections, calling for the addition of the warning that "adverse reactions to this product include anaphyl shock" and for the first time clarifying
-
Announcement of the General Administration on the revision of the instruction manual for a sweep of ointments
Time of Update: 2021-02-08
, take effective measures to do a good job of cleaning up the use of ointment and safety issues of publicity and training, guide doctors to use drugs rationally. All production enterprises should carry out post-market research on this product
-
Unique oral preparations should be perfected instructions
Time of Update: 2021-02-04
with the drug instructions of the functional treatment and usage of the use of the current no children to apply this product of systematic research materials, not recommended for children to use, once the drug appears red, rash, itching, palpitations, chest
-
Announcement of the General Administration on the revision of the instruction manual for the oral solution of compound licorice
Time of Update: 2021-02-02
of the Measures for the Administration of Drug Registration, and in accordance with the revised requirements of the description of the oral solution of compound licorice (see annex), file a supplementary application for revision of the instruction manual
-
The State Drug Administration revised the instruction manual for quick-acting heart-saving pills to increase the number of adverse reactions
Time of Update: 2021-01-31
replace the factory-issued drug instructions and labels within 9 months of filing. . Drug market license holders shall conduct in-depth research on the mechanism for the occurrence of new adverse reactions, take effective measures to do a good job
-
Blood house-by-blood, wet poison preparation instructions revised
Time of Update: 2021-01-30
In accordance with the revised requirements of the blood-for-blood preparation instructions, its "adverse reactions" item should include "adverse reaction monitoring data show that the following adverse reactions can be seen in this product: nausea
-
Instructions for the use of color-showing substation kits (end-point color-showing method, with ad parity reagents)
Time of Update: 2021-01-23
(4) experimental operation take the thermogen-free test tube, add 100 ml of bacterial endotoxin to check water, endotoxin standard solution, or for test products.
